ARTICLE | Clinical News
Tesamorelin ThGRF regulatory update
January 18, 2010 8:00 AM UTC
FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Feb. 24 to discuss an NDA from Theratechnologies for tesamorelin to treat excess abdominal fat in HIV-infected patients with li...